1. Home
  2. CCTG vs NRSN Comparison

CCTG vs NRSN Comparison

Compare CCTG & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CCSC Technology International Holdings Limited

CCTG

CCSC Technology International Holdings Limited

N/A

Current Price

$0.29

Market Cap

8.9M

Sector

N/A

ML Signal

N/A

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

N/A

Current Price

$2.04

Market Cap

7.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCTG
NRSN
Founded
1993
2017
Country
Hong Kong
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
7.6M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
CCTG
NRSN
Price
$0.29
$2.04
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $78.50
AVG Volume (30 Days)
★ 373.3K
17.2K
Earning Date
07-17-2026
09-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.08
$0.25
52 Week High
$5.64
$7.50

Technical Indicators

Market Signals
Indicator
CCTG
NRSN
Relative Strength Index (RSI) 26.22 32.23
Support Level N/A $0.61
Resistance Level $0.54 $7.50
Average True Range (ATR) 0.05 0.35
MACD -0.00 -0.13
Stochastic Oscillator 44.55 1.12

Price Performance

Historical Comparison
CCTG
NRSN

About CCTG CCSC Technology International Holdings Limited

CCSC Technology International Holdings Ltd, through its direct wholly-owned subsidiaries, is principally engaged in the manufacturing and sale of interconnect products, including connectors, cables and wire harnesses. The company produces both original equipment manufacturer (OEM) and original design manufacturer (ODM) interconnect products for manufacturing companies that produce end products, as well as for electronic manufacturing services (EMS) companies. The majority of the company's revenue is derived from the sale of Cable and wire harnesses, and Connectors. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: